|
1
|
Eddy GL, Bundy BN, Creasman WT, et al:
Treatment of (‘bulky’) stage IB cervical cancer with or without
neoadjuvant vincristine and cisplatin prior to radical hysterectomy
and pelvic/para-aortic lymphadenectomy: a phase III trial of the
gynecologic oncology group. Gynecol Oncol. 106:362–369. 2007.
|
|
2
|
Benedetti Panici P, Greggi S, Scambia G,
et al: Long-term survival following neoadjuvant chemotherapy and
radical surgery in locally advanced cervical cancer. Eur J Cancer.
34:341–346. 1998.PubMed/NCBI
|
|
3
|
Choi CH, Kim T, Lee J, et al: Phase II
study of neoadjuvant chemotherapy with mitomycin-c, vincristine and
cisplatin (MVC) in patients with stages IB2-IIB cervical cancer.
Gynecol Oncol. 104:64–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neoadjuvant Chemotherapy for Locally
Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant
chemotherapy for locally advanced cervical cancer: a systematic
review and meta-analysis of individual patient data from 21
randomised trials. Eur J Cancer. 39:2470–2486. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bae JH, Lee S, Lee A, et al: Neoadjuvant
cisplatin and etoposide followed by radical hysterectomy for stage
1B–2B cervical cancer. Gynecol Oncol. 111:444–448. 2008.PubMed/NCBI
|
|
6
|
Zhu Lihong, Wei Lihui, Li Xiaoping, et al:
Killing effect of paclitaxel liposome on cervical carcinoma SiHa
cells in vitro. Bull Chin Cancer. 17:704–707. 2008.
|
|
7
|
Shen Y and Wang Z: Total laparoscopic
radical hysterectomy for treatment of uterine malignant tumors:
analysis of short-term therapeutic efficacy. J Huazhong Univ Sci
Technol [Med Sci]. 30:376–379. 2010.PubMed/NCBI
|
|
8
|
Lai CH, Hsueh S, Chang TC, et al:
Prognostic factors in patients with bulky stage IB or IIA cervical
carcinoma undergoing neoadjuvant chemotherapy and radical
hysterectomy. Gynecol Oncol. 64:456–462. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katsumata N, Yoshikawa H, Hirakawa T, et
al: Phase III randomized trial of neoadjuvant chemotherapy (NAC)
followed by radical hysterectomy (RH) versus RH for bulky stage
I/II cervical cancer. ASCO Annu Meet Proc. 24:abs. 50132006.
|
|
10
|
Monk B, Huang HQ, Cella D, et al: Quality
of life outcomes from a randomized phase III trial of cisplatin
with or without topotecan in advanced carcinoma of the cervix: a
Gynecologic Oncology Group Study. J Clin Oncol. 23:4617–4625. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Buda A, Fossati R, Colombo N, et al:
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel,
ifosfamide, and cisplatin with ifosfamide and cisplatin followed by
radical surgery in patients with locally advanced squamous cell
cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio)
Italian Collaborative Study. J Clin Oncol. 23:4137–4145. 2005.
|
|
12
|
Moore DH, Blessing JA, McQuellon MP, et
al: Phase III study of cisplatin with or without paclitaxel in
stage IVB, recurrent, or persistent squamous cell carcinoma of the
cervix: a gynecologic oncology group study. J Clin Oncol.
22:3113–3119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park DC, Kim JH, Lew YO, Kim DH and
Namkoong SE: Phase II trial of neoadjuvant paclitaxel and cisplatin
in uterine cervical cancer. Gynecol Oncol. 92:59–63. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dueñas-Gonzalez A, López-Graniel C,
González-Enciso A, et al: A phase II study of multimodality
treatment for locally advanced cervical cancer: neoadjuvant
carboplatin and paclitaxel followed by radical hysterectomy and
adjuvant cisplatin chemoradiation. Ann Oncol. 14:1278–1284.
2003.
|
|
15
|
D’Agostino G, Distefano M, Greggi S, et
al: Neoadjuvant treatment of locally advanced carcinoma of the
uterine cervix with epirubicin, paclitaxel and cisplatin. Cancer
Chemother Pharmacol. 49:256–260. 2004.PubMed/NCBI
|
|
16
|
Zanetta G, Lissoni A, Pellegrino A, et al:
Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel
for locally advanced squamous-cell cervical cancer. Ann Oncol.
9:977–980. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang YY, Moon H, Cho SH, et al: Ten-year
survival of patients with locally advanced stage IB-IIB cervical
cancer after neoadjuvant chemotherapy and radical hysterectomy.
Gynecol Oncol. 82:88–93. 2001.PubMed/NCBI
|
|
18
|
Eddy GL, Manetta A, Alvarez RD, et al:
Neoadjuvant chemotherapy with Vincristin and cisplatin followed by
radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB
bulky cervical cancer: a gynecologic oncology group pilot study.
Gynecol Oncol. 57:412–416. 1995. View Article : Google Scholar
|
